Category: Business and Finance
- Aug 15, 2024
- Posted by Cillian Osterfield
Lupin Achieves Rapid USFDA Drug Approvals: A Boon for Shareholders
Lupin has secured its third USFDA approval for a new drug within a week. This streak of approvals is expected to positively impact the company's stock, drawing attention from investors and analysts. The approvals reflect Lupin's strong positioning in the global market, indicating growth and increased profitability for the company.
- Mar 22, 2024
- Posted by Cillian Osterfield
Eterna's Ownership Changes: Preline Limited's Tender Offer for Share Acquisition
In a strategic move to consolidate its ownership, Preline Limited, the majority shareholder of Eterna Plc, has obtained SEC's approval for a tender offer to purchase remaining shares from minor shareholders. Owning over 60% since 2021, Preline aims to strengthen its control further with this acquisition.
